Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | METAP1 | P53582 | 2/20 | 0.47 |
| ▸ | EIF2AK1 | Q9BQI3 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 3/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 3/20 | 0.41 |
| ▸ | DRD1 | P21728 | 3/20 | 0.41 |
| ▸ | DRD5 | P21918 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26780002 | 1.00 | CA1 (0.50) | CA1CA2CA4CA6METAP1 | |
| SCHEMBL7168538 | 0.84 | METAP1 (0.46) | CA1CA2CA4CA6METAP1 | |
| SCHEMBL29432302 | 0.80 | MAPT (0.45) | METAP1ACHECYP1A2ALDH1A1CYP2A6 | |
| SCHEMBL601330 | 0.80 | MAPT (0.45) | METAP1ACHECYP1A2ALDH1A1CYP2A6 | |
| SCHEMBL4581239 | 0.78 | METAP1 (0.63) | CA1CA2CA4CA6METAP1 | |
| SCHEMBL30777630 | 0.78 | METAP1 (0.63) | CA1CA2CA4CA6METAP1 | |
| SCHEMBL2914928 | 0.78 | DRD1 (0.58) | CA1CA2CA4CA6METAP1 | |
| SCHEMBL29633762 | 0.78 | DRD1 (0.58) | CA1CA2CA4CA6METAP1 | |
| SCHEMBL28941745 | 0.77 | HSP90AA1 (0.59) | CA1CA2CA4CA6METAP1 | |
| SCHEMBL26780005 | 0.77 | TYR (0.48) | CA1CA2CA4CA6MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092028-A1 | ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092028-A1 | ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES | DYRK1B, DYRK2, DYRK4 | CA1 2237/4885CA2 1473/4885CA4 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.